Shikuo Rong

Dr. Shikuo Rong


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SRShikuo Rong
Shikuo Rong
BDBao Dai
Bao Dai
CYChunrong Yang
Chunrong Yang
ZLZiteng Lan
Ziteng Lan
LWLinhe Wang
Linhe Wang
ZWZeyu Wu
Zeyu Wu
The heterogeneous nuclear ribonucleoprotein C (HNRNPC) plays a crucial role in tumorigenesis, yet its role in papillary thyroid carcinoma (PTC) remains elusive. Herein, we elucidated the function and molecular mechanism of HNRNPC in PTC tumorigenesis and progression. Our study unveiled a significant upregulation of HNRNPC in PTC, and knockdown of HNRNPC markedly inhibited the proliferation, invasion, and metastasis of BCPAP cells. Furthermore, HNRNPC modulated PKM alternative splicing in BCPAP cells primarily through m6A modification. Additionally, by upregulating PKM2 expression, HNRNPC promoted aerobic glycolysis in BCPAP cells, thereby facilitating malignant progression in PTC. In summary, our findings demonstrate that HNRNPC regulates PKM alternative splicing through m6A methylation modification and promotes the proliferation, invasion and metastasis of PTC through glucose metabolism pathways mediated by PKM2. These discoveries provide new biomarkers for screening and diagnosing PTC patients and offer novel therapeutic targets for personalized treatment strategies.

10 March 2025 in Cancer Letters
Verified
Journal Article
Closed access
LXLei Xu
Lei Xu
BDBao Dai
Bao Dai
LZLingyun Zhang
Lingyun Zhang
WCWeijian Chen
Weijian Chen
SRShikuo Rong
Shikuo Rong
ZWZeyu Wu
Zeyu Wu

18 February 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SRShikuo Rong
Shikuo Rong
BDBao Dai
Bao Dai
CYChunrong Yang
Chunrong Yang
ZLZiteng Lan
Ziteng Lan
LWLinhe Wang
Linhe Wang
ZWZeyu Wu
Zeyu Wu